PALOMAR MEDICAL TECHNOLOGIES LLC
DelistedCIK 881695fmd_0Z4R8J8W4KRS77KDG7PHWB9XNKManufacturing · Electromedical & Electrotherapeutic ApparatusTemplate: Standard
Coverage: Jan 01, 2009 to Mar 31, 2013, 14 periods
Latest annual · FY2012
Millions- Total revenues
- 81
- Gross profit
- 43
- Operating income
- (6)
- Net income
- (6)
- Free cash flow
- (8)
Latest quarter · Q1 FY2013
Millions- Total revenues
- 23
- Gross profit
- 13
- Operating income
- (1)
- Net income
- (1)
- Free cash flow
- 1
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2009 to FY2012
- +10.0%
PALOMAR MEDICAL TECHNOLOGIES LLC financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2012 | FY2011 | Change | Source |
|---|---|---|---|---|
| Revenue | $80.6 million | $103.4 million | -22.1% | 10-K 2013-03-14 · proof |
| Gross profit | $42.7 million | $60.7 million | -29.7% | 10-K 2013-03-14 · proof |
| Operating income | -$6 million | $10.7 million | -155.8% | 10-K 2013-03-14 · proof |
| Net income | -$6.2 million | $7.4 million | -183.1% | 10-K 2013-03-14 · proof |
| Cash from operating activities | -$7.5 million | $4.5 million | -266.2% | 10-K 2013-03-14 · proof |
| Free cash flow | -$8.1 million | $3.5 million | -330.4% | 10-K 2013-03-14 · proof |
| Total assets | $168.8 million | $178.1 million | -5.2% | 10-K 2013-03-14 · proof |
| Total liabilities | $18.3 million | $23.4 million | -22% | 10-K 2013-03-14 · proof |
| Cash and cash equivalents | $55.1 million | $63.1 million | -12.6% | 10-K 2013-03-14 · proof |
- What was PALOMAR MEDICAL TECHNOLOGIES LLC's revenue in fiscal 2012?
- PALOMAR MEDICAL TECHNOLOGIES LLC reported revenue of $80.6 million for fiscal 2012 (the year ended Dec 31, 2012), against $103.4 million the year before (-22.1%). Source: the 10-K filed with the SEC on Mar 14, 2013. SEC
- What was PALOMAR MEDICAL TECHNOLOGIES LLC's gross profit in fiscal 2012?
- PALOMAR MEDICAL TECHNOLOGIES LLC reported gross profit of $42.7 million for fiscal 2012 (the year ended Dec 31, 2012), against $60.7 million the year before (-29.7%). Source: the 10-K filed with the SEC on Mar 14, 2013. SEC
- What was PALOMAR MEDICAL TECHNOLOGIES LLC's operating income in fiscal 2012?
- PALOMAR MEDICAL TECHNOLOGIES LLC reported operating income of -$6 million for fiscal 2012 (the year ended Dec 31, 2012), against $10.7 million the year before (-155.8%). Source: the 10-K filed with the SEC on Mar 14, 2013. SEC
- What was PALOMAR MEDICAL TECHNOLOGIES LLC's net income in fiscal 2012?
- PALOMAR MEDICAL TECHNOLOGIES LLC reported net income of -$6.2 million for fiscal 2012 (the year ended Dec 31, 2012), against $7.4 million the year before (-183.1%). Source: the 10-K filed with the SEC on Mar 14, 2013. SEC
- What was PALOMAR MEDICAL TECHNOLOGIES LLC's cash from operating activities in fiscal 2012?
- PALOMAR MEDICAL TECHNOLOGIES LLC reported cash from operating activities of -$7.5 million for fiscal 2012 (the year ended Dec 31, 2012), against $4.5 million the year before (-266.2%). Source: the 10-K filed with the SEC on Mar 14, 2013. SEC
- What was PALOMAR MEDICAL TECHNOLOGIES LLC's free cash flow in fiscal 2012?
- PALOMAR MEDICAL TECHNOLOGIES LLC reported free cash flow of -$8.1 million for fiscal 2012 (the year ended Dec 31, 2012), against $3.5 million the year before (-330.4%). Source: the 10-K filed with the SEC on Mar 14, 2013. SEC
- What are PALOMAR MEDICAL TECHNOLOGIES LLC's total assets?
- As of Dec 31, 2012, PALOMAR MEDICAL TECHNOLOGIES LLC reported total assets of $168.8 million, against $178.1 million a year earlier (-5.2%). Source: the 10-K filed with the SEC on Mar 14, 2013. SEC
- What are PALOMAR MEDICAL TECHNOLOGIES LLC's total liabilities?
- As of Dec 31, 2012, PALOMAR MEDICAL TECHNOLOGIES LLC reported total liabilities of $18.3 million, against $23.4 million a year earlier (-22%). Source: the 10-K filed with the SEC on Mar 14, 2013. SEC
- What are PALOMAR MEDICAL TECHNOLOGIES LLC's cash and cash equivalents?
- As of Dec 31, 2012, PALOMAR MEDICAL TECHNOLOGIES LLC reported cash and cash equivalents of $55.1 million, against $63.1 million a year earlier (-12.6%). Source: the 10-K filed with the SEC on Mar 14, 2013. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:881695&period_type=annual&limit=5"Information only, not investment advice.